Market Closed -
Nasdaq
02:00:01 07/05/2024 am IST
5-day change
1st Jan Change
1.32
USD
+1.54%
+6.45%
-12.58%
OPKO Health, Inc. Announces Election of Alice Lin-Tsing Yu, M.D., Ph.D. to the Board of Directors At the AGM Held on June 24, 2021
June 26, 2021 at 01:56 am IST
OPKO Health, Inc. announced election of Alice Lin-Tsing Yu, M.D., Ph.D. to the Board of Directors at the AGM held on June 24, 2021.
Laboratory Corp of America to Acquire BioReference's Diagnostics Business Select Assets
28/03
MT
Entera Bio Announces Robust Pharmacokinetic Data for First-In-Class Oral Glp-2 Peptide Tablet Treatment for Patients with Short Bowel Syndrome
20/03
CI
Opko Health Insider Bought Shares Worth $444,300, According to a Recent SEC Filing
15/03
MT
Opko Health Insider Bought Shares Worth $463,750, According to a Recent SEC Filing
14/03
MT
Opko Health Insider Bought Shares Worth $559,380, According to a Recent SEC Filing
13/03
MT
Barrington Cuts Price Target on OPKO Health to $1.50 From $2, Maintains Outperform Rating
28/02
MT
Transcript : OPKO Health, Inc., Q4 2023 Earnings Call, Feb 27, 2024
28/02
Earnings Flash (OPK) OPKO HEALTH Reports Q4 Revenue $181.9M, vs. Street Est of $177.5M
28/02
MT
OPKO Health, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
28/02
CI
Drugmakers deepen efforts to tap into booming market for obesity drugs
27/02
RE
Opko Health Insider Bought Shares Worth $991,700, According to a Recent SEC Filing
22/02
MT
HealthSnap, Inc. announced that it has received $24.999999 million in funding from a group of investors
21/02
CI
OPKO Health, Inc. Announces the Cessation of Alexis Borisy as Member of the Board of Directors and Member of Compensation Committee of the Board
10/02
CI
NextPlat Preparing to Launch Opko Health Store on Alibaba's Tmall Global Platform
05/02
MT
Opko Health Insider Bought Shares Worth $488,650, According to a Recent SEC Filing
20/01
MT
Opko Health Insider Bought Shares Worth $386,200, According to a Recent SEC Filing
19/01
MT
Opko Health Insider Bought Shares Worth $954,300, According to a Recent SEC Filing
17/01
MT
Opko Health Insider Bought Shares Worth $480,379, According to a Recent SEC Filing
12/01
MT
Transcript : OPKO Health, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 03:45 PM
11/01
OPKO Health Closes Private Offering of $230 Million Convertible Notes Due 2029
10/01
MT
Opko Health Insider Bought Shares Worth $1,344,600, According to a Recent SEC Filing
08/01
MT
Opko Health Insider Bought Shares Worth $514,093, According to a Recent SEC Filing
06/01
MT
OPKO Health Prices $200 Million Convertible Senior Notes Offering
05/01
MT
Top Midday Decliners
05/01
MT
Sector Update: Health Care Stocks Advance Pre-Bell Thursday
04/01
MT
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company. The Company's diagnostics segment consists of the clinical laboratory operations of BioReference Health, LLC (BioReference), its point-of-care operations. Its pharmaceutical segment consists of the pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. Through BioReference, it operates specialized laboratory divisions, such as GenPath (Urology), GenPath (Oncology), and GenPath (Women's Health). It has two commercial stage pharmaceutical products and several pharmaceutical compounds and technologies in various stages of research and development for a range of indications and conditions, including Rayaldee, Rayaldee, Oxyntomodulin, Biologics, NGENLA Somatrogon, and Factor VIIa-CTP. It develops and manufactures specialty active pharmaceutical ingredients (APIs) through FineTech Pharmaceutical, Ltd.
More about the company
Last Close Price
1.32
USD
Average target price
4.25
USD
Spread / Average Target
+221.97%
Consensus
1st Jan change
Capi.
-12.58% 906M -17.25% 8.3B +49.55% 3.78B -8.23% 2.47B -34.62% 2.46B -9.24% 2.31B -4.14% 1.95B -17.46% 1.59B -37.88% 1.21B +8.08% 1.1B
Medical & Diagnostic Laboratories
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1